9889 related articles for article (PubMed ID: 1561799)
1. Cutaneous melanomas exhibiting unusual biologic behavior.
Shaw HM; Rivers JK; McCarthy SW; McCarthy WH
World J Surg; 1992; 16(2):196-202. PubMed ID: 1561799
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous melanomas that defy conventional prognostic indicators.
McCarthy WH; Shaw HM; McCarthy SW; Rivers JK; Thompson JF
Semin Oncol; 1996 Dec; 23(6):709-13. PubMed ID: 8970591
[TBL] [Abstract][Full Text] [Related]
3. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
[TBL] [Abstract][Full Text] [Related]
4. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
5. Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy.
Corsetti RL; Allen HM; Wanebo HJ
Ann Surg Oncol; 2000 Jul; 7(6):456-60. PubMed ID: 10894142
[TBL] [Abstract][Full Text] [Related]
6. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in thin cutaneous malignant melanoma.
Månsson-Brahme E; Carstensen J; Erhardt K; Lagerlöf B; Ringborg U; Rutqvist LE
Cancer; 1994 May; 73(9):2324-32. PubMed ID: 8168037
[TBL] [Abstract][Full Text] [Related]
8. Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma.
Baer SC; Schultz D; Synnestvedt M; Elder DE
Cancer; 1995 Dec; 76(11):2242-7. PubMed ID: 8635027
[TBL] [Abstract][Full Text] [Related]
9. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
10. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
11. Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases.
Shaw HM; McCarthy SW; McCarthy WH; Thompson JF; Milton GW
Histopathology; 1989 Sep; 15(3):257-65. PubMed ID: 2807184
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of prognostic indicators for early recurrence of cutaneous melanoma.
Matheson JA; Te Marvelde L; Mailer S; Speakman D; Spillane J; Henderson MA; Gyorki DE
Melanoma Res; 2017 Feb; 27(1):43-49. PubMed ID: 27753732
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
15. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
16. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients.
Machet L; Nemeth-Normand F; Giraudeau B; Perrinaud A; Tiguemounine J; Ayoub J; Alison D; Vaillant L; Lorette G
Br J Dermatol; 2005 Jan; 152(1):66-70. PubMed ID: 15656802
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of thick cutaneous melanoma of the trunk and extremity.
Coit D; Sauven P; Brennan M
Arch Surg; 1990 Mar; 125(3):322-6. PubMed ID: 2306180
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of primary cutaneous melanomas of the hands and feet.
Tseng JF; Tanabe KK; Gadd MA; Cosimi AB; Malt RA; Haluska FG; Mihm MC; Sober AJ; Souba WW
Ann Surg; 1997 May; 225(5):544-50; discussion 550-3. PubMed ID: 9193182
[TBL] [Abstract][Full Text] [Related]
19. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
Urist MM; Balch CM; Soong S; Shaw HM; Milton GW; Maddox WA
Cancer; 1985 Mar; 55(6):1398-402. PubMed ID: 3971310
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]